Individual InvestorsEmployee ShareholdersInstitutional InvestorsPrivate Companies Accredited Investors Seed & Angel InvestorsAsset Managers & Hedge Funds Family Offices Venture Capital Firms Wealth Managers & RIAsWho We Serve TradingDataRetirement Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge PriceA proprietary indicative price, calculated daily, for over 240 pre-IPO companies.Forge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Magnificent 7Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Omada Health IPO

omadahealth.comHealthcare / Digital Health

Omada Health was founded in 2011 by Adrian James, Andrew Di Michele, and Sean Duffy. CEO Duffy told Bloomberg in 2022 that while he intends to eventually take the company public, he "plans to stay independent for now...Especially given the current state of the public markets." Duffy added that "I tell the company that our job here is to make sure that when we make that flip to public it doesn’t feel like we’re doing anything differently." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Omada Health is a digital health firm that uses virtual consultations and monitoring devices to provide remote care for patients who suffer from chronic illness. In 2020 the company acquired Physera, a telehealth provider that specializes in musculoskeletal care. Omada Health has raised more than $440 million in venture capital funding from investors including Fidelity Management & Research Company, aMoon, Perceptive Advisors, Wellington Management, and Civilization Ventures. A $192 million Series E funding round brought the company's post-money valuation to more than $1 billion.

Buy and sell Omada Health stock Learn more about Omada Health stock

Learn More About Omada Health

To invest in Omada Health pre-IPO

Can you invest in Omada Health pre-IPO?

Omada Health is a privately held company and is not publicly traded, therefore investing in Omada Health pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Omada Health before it goes public?

You can seek to sell your shares in Omada Health while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Omada Health shares?

To determine the value of your Omada Health shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Omada Health shares. You can also learn more about how to sell your private shares before getting started.

Is Omada Health a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Omada Health potential IPO

Will Omada Health go IPO?

Omada Health has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Omada Health’s IPO price?

The Omada Health IPO price does not exist at this time, as Omada Health is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Omada Health register for Forge Markets, today.

When was Omada Health founded?

Omada Health was founded in 2011.

What is Omada Health funding to date?

Omada Health has raised $919.75MM to date.

Who are Omada Health’s major investors?

Civilization Ventures

Founder Collective

Us Venture Partners

Humana

Cigna

Sanofi Genzyme Bioventures

Designer Fund

Undisclosed Investors

Fidelity

Humana Ventures

Perceptive Advisors

The Vertical Group

Triplepoint Capital

Wellington Management

Kapor Capital

Norwest Venture Partners

Cigna Ventures

Kaiser Permanente Ventures

Providence Ventures

Healthtech Capital

Ideo Futures

Andreessen Horowitz

Rock Health

New Enterprise Associates

Sanofi-Genzyme Bioventures

U.S. Venture Partners

Amoon

Ge Ventures

Drx Capital

Omada Health Funding Rounds and Valuation

Funding History Chart

Funding Round Details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	02/23/2022	Series E	$192MM	$xx.xx	$1.02B	Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management
Price per Share $xx.xx Shares Outstanding 32,025,620 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management
	03/16/2021	Series D-1	$27MM	$xx.xx	$780.77MM	Undisclosed Investors
Price per Share $xx.xx Shares Outstanding 4,503,601 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Undisclosed Investors
	05/19/2020	Series D	$112.47MM	$xx.xx	$612.85MM	Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management
Price per Share $xx.xx Shares Outstanding 22,330,212 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management
	05/10/2017	Series C-1	$49.99MM	$xx.xx	$320.25MM	Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners
Price per Share $xx.xx Shares Outstanding 13,357,797 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners
	10/01/2015	Series C	$48.67MM	$xx.xx	$216.43MM	Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners
Price per Share $xx.xx Shares Outstanding 15,385,707 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners
	04/09/2014	Series B	$23.33MM	$xx.xx	$60.57MM	Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners
Price per Share $xx.xx Shares Outstanding 19,724,378 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners
	03/21/2013	Series A	$6.43MM	$xx.xx	$16.11MM	Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners
Price per Share $xx.xx Shares Outstanding 12,027,426 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners

Access Stock Price

Last Funding Round
Cerebras	$40.08	$xx.xx	Series F-1	$2.84B	$xx.xx	$85MM
CoreWeave	--	$xx.xx	Series C	$19B	$xx.xx	$1.15B
Klarna	$370.00	$xx.xx	Unknown	$6.7B	$xx.xx	--
Liquid Death	$9.72	$xx.xx	Series F-1	$1.4B	$xx.xx	$67.61MM
Circle	$24.71	$xx.xx	Series F	$8.05B	$xx.xx	$401MM
Netskope	$10.75	$xx.xx	Series H	$7.5B	$xx.xx	$300MM
Cohesity	$15.66	$xx.xx	Series H-1	$4.69B	$xx.xx	$27.5MM
Chime	$24.87	$xx.xx	Series G	$24.93B	$xx.xx	$1.1B
Turo	$12.97	$xx.xx	Series E	$1.24B	$xx.xx	$240.52MM
Dataminr	$13.75	$xx.xx	Series F	$4.1B	$xx.xx	$475MM

Updated on: Dec 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Updated on: Dec 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.

Omada Health IPO